Multiple methods within a single trial [Regulatives / Guidelines]

posted by wienui  – Germany/Oman, 2019-03-13 19:44 (1958 d 19:30 ago) – Posting: # 20027
Views: 4,966

Dear Ohlbe,

❝ I would reverse the question: why would you use two different methods, or two different technologies, within a single BE trial, with the risk of increasing variability? We're not talking of 2 different trials here (where one can be done at one CRO and the other at another CRO, with a different method).


Please think about very big clinical trials which required a multi-centers ( e.g for Anti-cancer drugs), you deal here with different CRO's which could have different technologies.

Best regards,
Osama

Cheers,
Osama

Complete thread:

UA Flag
Activity
 Admin contact
23,117 posts in 4,859 threads, 1,647 registered users;
38 visitors (0 registered, 38 guests [including 10 identified bots]).
Forum time: 16:15 CEST (Europe/Vienna)

You can’t really say “similar” if it’s the same again you want.
“Similar” means something different.    Anthony Burgess

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5